Who
Robert McNamara
Director
Company insider
Files Form 4 as: Director, Avita Medical; Director, Axonics; Director, Xtant Medical Holdings; Director, Alpha Teknova; Chief Financial Officer, Ldr Holding; SVP CFO, Accuray.
In numbers
- Trades disclosed
- 155
- Buys
- 4
- Sells
- 12
- Bought
- $287K
- Sold
- $3.4M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 31 Aug 2007
- Last trade
- 20 Jan 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —22,214 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,133 at $0.00 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,133 at $0.00 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —22,214 | filing |
| 28 Aug 2025filed 29 Aug 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Bought | $45K10,000 at $4.50 | filing |
| 19 Aug 2025filed 20 Aug 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Bought | $50K10,000 at $5.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Bought | $91K11,000 at $8.30 | filing |
| 20 Feb 2025filed 20 Feb 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Bought | $101K10,000 at $10.09 | filing |
| 21 Jan 2025filed 5 Jun 2025 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —4,295 at $0.00 | filing |
| 21 Jan 2025filed 5 Jun 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —10,022 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonicsoption or derivative | SEC FORM 4 Code D | $369K10,000 at $36.90 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonicsoption or derivative | SEC FORM 4 Code D | $113K3,333 at $33.85 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonicsoption or derivative | SEC FORM 4 Code D | $281K5,000 at $56.20 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonics | SEC FORM 4 Code D | $1.1M14,861 at $71.00 | filing |
| 19 Aug 2024filed 20 Aug 2024 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | $90K10,000 at $9.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | XTNT Xtant Medical HoldingsMedical Devices | SEC FORM 4 Code A | —162,162 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —3,943 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —9,200 | filing |
| 30 Nov 2023filed 6 Feb 2024 | TKNO Alpha Teknovaoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —31,959 at $0.00 | filing |
| 31 Aug 2023filed 6 Feb 2024 | TKNO Alpha Teknovaoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —12,292 at $0.00 | filing |
News
Ambu A/S (OTCMKTS:AMBBY) & Avita Medical (NASDAQ:RCEL) Head to Head AnalysisRCEL · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Robert McNamara; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.